| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 180.79B | 178.78B | 170.77B | 163.31B | 147.88B | 108.89B |
| Gross Profit | 41.08B | 40.08B | 29.69B | 26.14B | 27.00B | 24.33B |
| EBITDA | 20.61B | 20.37B | 11.03B | 7.68B | 10.00B | 9.81B |
| Net Income | 6.08B | 6.29B | 8.45B | 7.91B | 3.66B | 2.77B |
Balance Sheet | ||||||
| Total Assets | 192.18B | 202.20B | 191.43B | 196.12B | 189.50B | 146.71B |
| Cash, Cash Equivalents and Short-Term Investments | 36.72B | 40.60B | 25.07B | 28.00B | 31.48B | 17.80B |
| Total Debt | 45.43B | 48.62B | 44.73B | 48.00B | 30.03B | 19.83B |
| Total Liabilities | 76.94B | 82.85B | 74.08B | 83.54B | 79.57B | 55.03B |
| Stockholders Equity | 110.72B | 114.61B | 112.17B | 107.18B | 101.21B | 85.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.71B | 5.38B | -11.50B | -3.92B | 5.44B |
| Operating Cash Flow | 0.00 | 22.59B | 12.74B | 6.23B | 6.36B | 11.12B |
| Investing Cash Flow | 0.00 | -5.63B | -6.67B | -21.56B | 344.00M | -4.02B |
| Financing Cash Flow | 0.00 | -1.69B | -8.99B | 11.65B | 6.57B | -4.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.35B | 5.17 | ― | 1.91% | 2.73% | 59.02% | |
76 Outperform | ¥215.66B | 12.35 | 13.33% | 3.47% | 4.21% | 23.86% | |
72 Outperform | ¥76.28B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
71 Outperform | ¥33.08B | 7.15 | ― | 2.84% | 6.64% | 10.48% | |
68 Neutral | ¥107.39B | 10.22 | ― | 3.97% | 3.69% | -27.70% | |
65 Neutral | ¥49.50B | -19.07 | ― | 2.12% | 3.82% | -131.02% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |